Four breakthrough studies could revolutionize tuberculosis treatment

Four breakthrough studies could revolutionize tuberculosis treatment

Publication date: Mar 24, 2025

In infected mice, 6 weeks of nanoparticle treatment significantly reduced the amount of M. tuberculosis in the lungs. To get the TB drug clofazimine across the blood-brain barrier, researchers have encapsulated it inside tiny particles and created a nasal spray. To develop a faster method, researchers targeted a protein that the bacterium uses to steal iron ions from its host’s cells. If M. tuberculosis reaches cerebrospinal fluid, the result can be tuberculous meningitis – a life-threatening inflammation around a person’s brain and spinal cord. Currently, testing saliva samples for M. tuberculosis is time-consuming because of the bacterium’s slow growth and resistance to stains used in imaging. A 4-week treatment significantly reduced the bacterial burden within the animals’ brains and lungs compared to untreated mice. A type of white blood cell called a macrophage gets taken over during a tuberculosis infection, becoming an incubator for the pathogen.

Concepts Keywords
Emailing Acs
Lethal Bacterium
Mycobacterium Blood
Sugar Infectious
Iron
Light
March
Meningitis
Mice
Particles
Tb
Treatment
Tuberculosis
Tuberculous

Semantics

Type Source Name
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH causes
disease IDO bacteria
drug DRUGBANK Clofazimine
disease MESH inflammation
disease MESH tuberculous meningitis
disease MESH Infectious Diseases
disease IDO pathogen
disease MESH infection
disease IDO cell
disease IDO blood
disease IDO host
drug DRUGBANK Iron
disease IDO protein

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *